Therefore, here, we evaluate all existing evidence indicating functional CD44 and STAT3 cooperation in the context of tumor metastatic progression, therapy resistance and immunosuppression with the focus on ovarian cancer. This evidence concerns the gene STAT3 and ovarian cancer.